B + B FAR EAST LIMITED

Business Description

B + B FAR EAST LIMITED is registered as a business entity on 28 December 1989 (35.2 years ago) structured as a Foreign Company Registered In Singapore (Foreign Company) with 3 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) S89FC4073H. The business official address is located at 21 Collyer Quay #15-01, Hongkong Bank Building, Singapore 49320 in the primary industry of 41009: Building Construction N.e.c. using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as KIER FAR EAST LIMITED, BEAZER FAR EAST LIMITED. The business annual account filing date falls on 28 December and is no longer operational with the status of 'na'. The business paid up share capital is HKD 0, with preference share capital of HKD 0, and other share capital at HKD 0.

In the past 365 days, B + B FAR EAST LIMITED has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is registered as a foreign company, it is the offshore branch of a parent orgnisation and more research should to be done to understand its local presence. The appointment of PRICEWATERHOUSECOOPERS LLP as auditor indicates that the business is medium to large sized as it is required to meet additional regulatory requirements either due to reported revenue or assets exceeding SGD 10 million or has more than 50 employees in the previous two fiscal years.

B + B FAR EAST LIMITED is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023